Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2000
11/02/2000WO2000064485A2 Specifically targeted catalytic antagonists and uses thereof
11/02/2000WO2000064484A2 Conjugate having a cleavable linkage for use in a liposome
11/02/2000WO2000064483A2 Releasable linkage and compositions containing same
11/02/2000WO2000064482A1 Nerve cell growth modulators (amphibodies)
11/02/2000WO2000064481A1 Controlled release of growth factors from heparin containing matrices
11/02/2000WO2000064480A1 Treatment, imaging and diagnosis of disease using an agent which binds alfa5-integrin
11/02/2000WO2000064475A1 Treatment of metastatic cancer through mts-1 gene
11/02/2000WO2000064471A1 Model membrane systems
11/02/2000WO2000064468A2 Therapeutic compositions and methods for enhancing angiogenesis
11/02/2000WO2000064450A1 Pharmaceutical composition
11/02/2000WO2000064447A1 Novel compositions comprising trimetrexate and methods of their synthesis and use
11/02/2000WO2000064444A1 Novel pharmaceutical compositions comprising 2-isoxazole-8-aminotetralin derivatives
11/02/2000WO2000064442A1 Novel anticoagulant injectable composition
11/02/2000WO2000064440A1 Treatment of and/or prophylaxis against brain and spinal cord injury
11/02/2000WO2000064435A1 Percutaneous absorption preparations containing oxybutynin
11/02/2000WO2000064434A1 Percutaneous preparations containing oxybutynin
11/02/2000WO2000064427A2 Lamivudine containing pharmaceutical formulation
11/02/2000WO2000064419A1 Transdermal therapeutic system with a highly effective neuroleptic agent
11/02/2000WO2000064418A2 Transdermal therapeutic system with neutralized acrylic adhesive patch
11/02/2000WO2000064415A1 Method for producing a water-insoluble amorphous or partially amorphous controlled release matrix
11/02/2000WO2000064414A2 Solid pharmaceutical formulations of acid-sensitive proton-pump blockers
11/02/2000WO2000064413A1 Antibody and polyalkylene glycol-bonded liposome
11/02/2000WO2000064273A1 Complete feed for fish larvae and method for preparing same
11/02/2000WO2000042987A3 Targeted vesicular constructs for cytoprotection and treatment of h. pylori infections
11/02/2000WO2000041528A3 Improved controlled release compositions and method
11/02/2000WO2000040172B1 Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents
11/02/2000WO2000038626A3 Substrate composition and method of use for sequestration of skin irritants
11/02/2000WO2000033878A3 Stabilization of macrolides
11/02/2000WO2000030622A3 Utilisation of dialkylfumarates for treating host-versus-graft reactions and auto-immune diseases
11/02/2000WO2000029029A9 Compositions and methods for producing vascular occlusion
11/02/2000WO2000029024A9 Formulation of adenovirus for gene therapy
11/02/2000WO2000004926A3 Conjugates for treating inflammatory disorders and associated tissue damage
11/02/2000EP1048301A1 Sustained release compositions, process for producing the same and utilization thereof
11/02/2000EP1048300A1 Disintegrating agent
11/02/2000EP1047792A1 A method for depopulating of vertebrate testis and for generation of transgenic species
11/02/2000EP1047774A1 Methods and compositions for gene delivery
11/02/2000EP1047732A1 Color shifting film glitter
11/02/2000EP1047701A1 Mitochondrially targeted antioxidants
11/02/2000EP1047457A2 USE OF RADIOLABELED MONOCLONAL IgM IN THERAPY FOR CANCER AND AUTOIMMUNE DISEASE
11/02/2000EP1047456A1 A method and composition for cancer treatment by enzymatic conversion of soluble radioactive toxic agents
11/02/2000EP1047452A1 Conjugates comprising two active agents
11/02/2000EP1047451A1 Use of heat shock proteins to deliver moieties into cells
11/02/2000EP1047433A1 Cellulose derivatives and colorectal cancer risk reduction
11/02/2000EP1047430A1 A gel-form pharmaceutical preparation
11/02/2000EP1047422A1 Use of histamine for elevating blood histamine levels
11/02/2000EP1047415A1 Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
11/02/2000EP1047409A1 Tts containing an antioxidant
11/02/2000EP1047407A1 Process for manufacturing bite-dispersion tablets
11/02/2000EP1047406A1 Autoclavable pharmaceutical compositions containing a chelating agent
11/02/2000EP1047405A1 Self-foaming cleansing systems
11/02/2000EP1047372A1 Stable oil-in-water emulsion, method for preparing same and use in cosmetics and dermatology
11/02/2000EP0869986B1 Polymers with controlled physical state and bioerodibility
11/02/2000EP0812207B1 Morphogen-induced dentine regeneration
11/02/2000EP0586524B2 Improvements in or relating to contrast agents
11/02/2000CA2371216A1 Pseudotyped retroviral vector for gene therapy of cancer
11/02/2000CA2371046A1 Therapeutic compositions and methods for enhancing angiogenesis
11/02/2000CA2370952A1 Hyperbranched polymeric micelles for encapsulation and delivery of hydrophobic molecules
11/02/2000CA2370769A1 Controlled delivery of bisphosphonates
11/02/2000CA2370592A1 Percutaneous absorption preparations containing oxybutynin
11/02/2000CA2370581A1 Novel pharmaceutical compositions comprising 2-isoxazole-8-aminotetralin derivatives
11/02/2000CA2370576A1 Novel anticoagulant injectable composition
11/02/2000CA2370302A1 Insulin crystals for pulmonary administration
11/02/2000CA2370284A1 Membrane disruptive peptides covalently oligomerized
11/02/2000CA2370043A1 Liposome bonded with antibody and polyalkylene glycol
11/02/2000CA2369999A1 Enzymatically activated polymeric drug conjugates
11/02/2000CA2369951A1 Solid pharmaceutical formulations of acid-sensitive proton-pump blockers
11/02/2000CA2369579A1 Controlled release of growth factors from heparin containing matrices
11/02/2000CA2368793A1 Releasable linkage and compositions containing same
11/02/2000CA2368213A1 Specifically targeted catalytic antagonists and uses thereof
11/02/2000CA2367980A1 Complete feed for fish larvae and method for preparing same
11/01/2000CN1272063A Prostaglandin product
11/01/2000CN1272062A Immunogenic conjugates comprising group meningococcal porin and an i (H. influenzae) polysaccharide
11/01/2000CN1272059A Carotenoid formulation
11/01/2000CN1272058A Perforated microparticles and methods of use
11/01/2000CN1271579A Compound vitamin for health of cardiovascular
11/01/2000CN1271577A Medicine preparation and its use and the use of high grade primary alcohol mixture
10/2000
10/31/2000US6140518 For use in the prevention or treatment of osteoporosis and related bone disorders.
10/31/2000US6140374 Propofol composition
10/31/2000US6140373 Propofol composition
10/31/2000US6140359 Injectable composition
10/31/2000US6140312 Nontoxic, for treating skin diseases
10/31/2000US6140121 Contacting sample containing sperm with solution comprising hexuronic acid monomer or with solution comprising polymer comprising hexuronic acid and arabinose or galactose to form a mixture, separating sperm
10/31/2000US6140120 Regulated transcription of targeted genes and other biological events
10/31/2000US6140100 Cell-targeting molecule comprising a mutant human carboxypeptidase A
10/31/2000US6140064 Identifying ligands, and inhibitors (e.g., antagonists) or promoters (e.g., agonists) of receptor function, including methods in which host cells comprising a nucleic acid encoding a cxcr3 or variant thereof are used in an assay to identify
10/31/2000US6139882 Drugs, foods, beverages, animal feed
10/31/2000US6139877 Spheroids containing tiagabine, preparation process and pharmaceutical compositions
10/31/2000US6139876 Gel with increased oxygen content
10/31/2000US6139875 Aqueous enteric coating composition and low gastric permeability enteric coating
10/31/2000US6139870 Stabilized nanoparticles which are filterable under sterile conditions
10/31/2000US6139869 Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane
10/31/2000US6139866 Tape formulation for percutaneous administration containing fentanyi
10/31/2000US6139865 Taste-masked microcapsule compositions and methods of manufacture
10/31/2000US6139863 Suppositories
10/31/2000US6139855 An enhancer for the performance of a biological active in a topically applied composition comprising an ionized water including an acid water and a basic water
10/31/2000US6139850 A strontium compound as antiallergens to provide fast-acting, efficient and safe topical skin anti-irritant effects
10/31/2000US6139836 Lysed and partially lysed red blood cells are concentrated prior to introduction of biologically active agent; resultant carrier red blood cells are stable for extended period of time and can be used for systemic or targeted delivery of drugs
10/31/2000US6139826 Hair styling composition containing graft copolymer has an organic hydrophilic backbone and grafts comprising a hydrophobic macromonomer chemically joined and pendant thereto and a hydrophilic solvent
10/31/2000US6139818 Method of making ultrasonic contrast agent
10/31/2000US6138680 Method for destroying retinal pigment epithelial cells
1 ... 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 ... 1712